Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-27 Sale | 2025-10-29 1:13 pm | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 459 | $26.68 | $12,246 | 1,980,688 (Indirect) | View |
| 2025-10-01 Sale | 2025-10-03 4:15 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 467 | $24.53 | $11,456 | 44,045 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:10 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 373 | $24.53 | $9,150 | 116,921 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:05 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $24.57 | $1,228,323 | 1,153,339 (Indirect Direct) | View |
| 2025-07-30 Sale | 2025-08-01 09:36 am | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 48,374 | $20.5 | $991,667 | 3,213,581 (Indirect) | View |
| 2025-07-01 Sale | 2025-07-03 5:30 pm | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 1,250 | $19.17 | $23,962 | 64,864 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 9:53 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 5,674 | $18.35 | $104,122 | 117,294 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 9:52 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 30,663 | $18.35 | $562,684 | 1,089,249 (Indirect Direct) | View |
| 2025-04-01 Sale | 2025-04-03 9:51 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 7,434 | $18.35 | $136,418 | 190,216 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 9:50 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 3,015 | $18.35 | $55,330 | 44,512 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 9:50 pm | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 30,563 | $17.92 | $547,835 | 65,742 (Direct) | View |
| 2025-02-18 Sale | 2025-02-20 4:10 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 6,287 | $35 | $220,045 | 37,527 (Direct) | View |
| 2025-02-14 Sale | 2025-02-19 4:10 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 10,000 | $34 | $340,000 | 113,378 (Direct) | View |
| 2025-01-30 Sale | 2025-02-03 4:05 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 30,000 | $26.75 | $802,484 | 1,166,659 (Indirect Direct) | View |
| 2025-01-02 Sale | 2025-01-06 5:49 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 1,241 | $24.68 | $30,628 | 102,968 (Direct) | View |
| 2025-01-02 Sale | 2025-01-06 5:48 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 1,117 | $24.68 | $27,568 | 43,814 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-06 Gift | 2025-10-08 3:37 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 1,232,434 | $0 | 1,981,147 (Indirect) | View |
| 2025-10-01 Exercise | 2025-10-03 4:05 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $0 | 1,153,339 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:05 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $0.67 | 1,153,339 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | Walsh Kathleen E Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | Fishman Mark Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2025-06-04 | Beam Therapeutics Inc. | BEAM | Shaw Christi Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | MARAGANORE JOHN Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2025-06-04 | Beam Therapeutics Inc. | BEAM | Guindo Chirfi Director | 33,662 | $0 | 33,662 (Direct) | View |
Ownership | 2025-04-10 09:36 am | N/A N/A | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 0 | $0 | 3,261,955 (Indirect) | View |
| 2025-03-31 Option Award | 2025-04-02 7:21 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 20,000 | $0 | 122,968 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 7:18 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 27,500 | $0 | 96,305 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 7:13 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 35,000 | $0 | 197,650 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 7:11 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 10,000 | $0 | 47,527 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 7:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 77,500 | $0 | 1,119,159 (Direct) | View |
| 2025-01-30 Exercise(A) | 2025-04-02 4:05 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 30,000 | $0 | 1,037,995 (Direct) | View |
| 2025-01-30 Exercise(A) | 2025-04-02 4:05 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 30,000 | $0.67 | 1,037,995 (Direct) | View |
| 2025-02-14 Exercise | 2025-02-19 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 10,000 | $7.22 | 113,378 (Direct) | View |
| 2025-02-14 Exercise | 2025-02-19 4:10 pm | N/A 2029-05-16 | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 10,000 | $0 | 113,378 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-03 4:05 pm | N/A 2035-01-31 | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-03 4:05 pm | N/A 2035-01-31 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 70,000 | $0 | 70,000 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-03 4:05 pm | N/A 2035-01-31 | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-03 4:05 pm | N/A 2035-01-31 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 155,000 | $0 | 1,166,659 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-03 4:05 pm | N/A 2035-01-31 | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-02 8:04 pm | N/A 2034-12-31 | Beam Therapeutics Inc. | BEAM | Emany Sravan Kumar Chief Financial Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-12-17 Exercise | 2024-12-19 4:10 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 53,500 | $0 | 169,155 (Direct) | View |
| 2024-12-17 Exercise | 2024-12-19 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 53,500 | $0.67 | 169,155 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 07:22 am | N/A 2034-12-02 | Beam Therapeutics Inc. | BEAM | Guindo Chirfi Director | 39,086 | $0 | 39,086 (Direct) | View |